Chemotherapy: Impact on hs-CRP Levels in Chronic Myeloid Leukemia

Journal Title: Scholars Academic Journal of Biosciences - Year 2016, Vol 4, Issue 12

Abstract

Leukemias are malignant neoplasms of hematopoietic stem cells, characterized by diffuse replacement of the marrow by neoplastic cells. It is one of the leading causes of cancer deaths.The present study was conducted in the Department of Biochemistry, in collaboration with the Department of Medicine (Clinical Haematology unit); Pt. B.D. Sharma, Post Graduate Institute of Medical Sciences, Rohtak. Thirty patients of Chronic Myeloid leukemia after confirmed diagnosis were taken up for study. CML patients were treated by imatinib therapy. Serum hs-CRP was assayed by Enzyme Linked Immunosorbent Assay (ELISA) in newly diagnosed patients and in thirty age and sex matched healthy controls. The test was repeated at first complete remission or at 3 months (whichever is earlier) in CML patients. Group I: Control group- age and sex matched healthy volunteers. Group II: CML patients at the time of diagnosis (before imatinib therapy).Group III: CML patients at first complete remission or at 3 months of imatinib therapy (whichever is earlier).Serum hsCRP levels were significantly increased (p=0.000) in group II and group III (14.75±6.51 mg/L and 9.81±4.64 mg/L respectively) as compared with group I (2.75±1.29 mg/L). In group III hsCRP levels (9.81±4.64 mg/L) were decreased significantly (p=0.001) after imatinib therapy as compared with group II.Our study revealed that hsCRP could be useful marker in determining disease progression or monitor the effectiveness of treatment in leukemic patients as increased levels are seen in CML cases both before and after chemotherapy as compared with their age matched healthy controls. Keywords:Leukemia, CML, Imatinib, hsCRP.

Authors and Affiliations

Ghalaut VS, Saurabh K, Sikka R, Bala J

Keywords

Related Articles

Suppression of γ-irradiation-induced deletion mutations under Parp-1 deficiency in mice

Abstract: Poly (ADP-ribose) polymerase-1 (Parp-1) functions in DNA repair, acting as a sensor for DNA strand breaks and recruiting DNA repair proteins to the site of DNA damage. To investigate the impact of Parp-1 in pro...

Sturge-Weber Syndrome in A Neonate: An Unique Presentation

Abstract: The Sturge-Weber Syndrome, also known as encephalotrigeminal angiomatosis, is a rare vascular neurocutaneous syndrome. It is characterised by port wine stain, seizure, and intracranial calcification. The facial...

Histomorphological Spectrum of Helicobacter Pylori Positive Gastric Biopsies – A 2 Year Prospective Study

Abstract: Helicobacter pylorus (H. pylori) a spiral, urease producing organism and is a important pathogenic factor in peptic ulcer disease (PUD). Extensive molecular studies suggest that the bacteria cause gastritis by...

Effect of 6 Weeks of Kapalabhati Pranayama Training on Peak Expiratory Flow Rate in Young, Healthy, Volunteers

Pranayama are breathing techniques that exert profound physiological effects on pulmonary, cardiovascular and intellectual higher centre functions. The science of pranayama deals with the control and enrichment of this v...

Bacteriological analysis of plastic and wood chopping boards

Abstract: This study was conducted to compare the microbial load of used plastic and wood chopping board samples and to determine the presence of Salmonella sp. and other Enterobacteriaceae species from the samples. Plat...

Download PDF file
  • EP ID EP372478
  • DOI -
  • Views 121
  • Downloads 0

How To Cite

Ghalaut VS, Saurabh K, Sikka R, Bala J (2016). Chemotherapy: Impact on hs-CRP Levels in Chronic Myeloid Leukemia. Scholars Academic Journal of Biosciences, 4(12), 1082-1086. https://europub.co.uk./articles/-A-372478